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1.

lNT.RODUCTION

After a cursory perusal of any textbook or monograph, l have
always read the introduction before making any concentrated e1Tort to
digest the contents.

The incentive prompting an individual to write any

document is most interesting to me, and this usually manifests itself
in the author's explanatory introduction or pre1·ace.

Many times it is

because the author sore.Ly 1·ee.ls the need of a more comprehensive work
on a particular subject, other times because he desires to incorporate
for posterity certain observations and facts noticeably omitted by
other authors, or even, perhaps, to give vent to a literary inclination.
l

must confess that none of these reasons prompted my work.

This paper

is required - but I have attempted to present a nom-to-well understood
subject, in as complete a manner as is possible under existing conditions
and restrictions.

bione or the material included herein is original, but

numerous references to journals, textbooks, and monographs have assisted
me in i'amiliarizing myself with the countless sources of in1'ormation at
the disposal oi' one imbued with the scientific curiosity and ambition which
if' exercised, will elevate the

11

symptom-treater 11 to a more scientific

student of medicine.
I am gratei'ul to the office oi' JJrs. Lord, Schrock and Johnson,
and the University Hospital, for the use of their 1'1.Les and the roentgenogram photographs used herein.
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Pare (75) in the 16th century described benign tumors of the maxilla
which were cured by excision, Beclard (7) in 1827 a medullary, vascular, "not
cancerous" bone tumour, and Warren in 1837 a benign central tumor of the femur.
Lebert (58) in.1845 recognized giant cells in certain medullary tumors, and
described yellow deposits in these masses as xanthosis, but did not differentiate them from malignant sarcoma.

Robin (81) in 1849 described two

cellular elements of the medulla of bone which he called
and "cellules myeloplaques".

11

cellules medullaires"

The former were spherical or polyhedral, 0.015-

0.018 mm. in diameter, with a single nucleus of 6-7 microns,. the cytoplasm
granular.

They were more abundant in the young than in the old in the inter-

stices between the fat cells and vessels of the bone marrow.
11

The latter type,

cellules myeloplaques", he thought were a minimal normal constituent of adult

and aged bone, becoming tumorous when in abundance.

They are described as

polygonal or irregular spheroids, 0.05-0.08 mm. in diameter, with finely granular cytoplasm containing six to ten nuclei, each of whicy had one or two
nucleoli in their center.

This is described first in a case of supposed

"spina ventosa", an expansile tumor of the tibia.
had been used also by
toids".

Dupuytre~

The term "spina ventosa"

for a similar lesion along with "fongus hema-

Eugene R_elaton (71) considered that Robin deserved credit for the

real identification of the "myeloplaques" as normal minor constituents of bone
marrow.

Lebert (SS) and Muller (70) had called the giant cells "mother cells";

Kolliker (54) considered them osteoclasts.
lelaton (71) in his thesis of 186o offered a simple but none the
less adequate definition of this neoplasm -

11

tumeur a myeloplaxes" - a

particular kind of accidental tissue production whose fundamental architecture
is characterized, not by simple presence of, but by the predominance of the

,.,,.....
,
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HISTORY OF GIANT-CELL TUMOR
anatomic elements called "myeloplaques".
From this point he proceeded to indicate four essential types of
this class of tumor:
(1) The solid or meaty (typical);
(2) The fibroid, with more fibroblastic proliferation
in the stroma;
(3) The 11 graisseuse" or xanthoid;
(4) The vascular.
The cystic changes not uncommonly seen were considered then as simple
degeneration of the tumor.

Such as showed hemorrhage into these cystic areas

were considered the result of natural extravasation from the new-formed vessels
of the tumor (probable so-called bone aneurysm).
Gross (41) in 1879 reviewed the history and morphology of giant-cell
sarcoma emphasizing, against Billroth's opinion, the benign prognostic importance of giant-cell structure, and showing in four fatal cases that this tumor
might become malignant.

Gross' description of the origin, structure, clinical

characters, and treatment of bone sarcoma stands today as the classic contribution on this subject.
v. Be:rgmann,Mickulicz and v. Bramann (9) recognized the benign nature
of giant-cell tumors during the remaining few years of the 19th century.
Hinds (47) in 1898, believing this tumor to be benign, successfully
treated it by scraping and reported no recurrences after eighteen years of
careful study.
Bloodgood (12), Mallory (64) and Coley (23) are especially identified
with the exhaustive study and recognition of giant-cell tumors, during the
first part of the twentieth century.

HISTORY OF GIANT-CELL TUMOR
Various names have been given this lesion, beginning with tumeur a
myeloplaxes by Nelaton (71), myeloid sarcoma - a name almost universally used
from 1870 to 1910, and still used in British literature, hemorrhagic osseous
dystrophia, giant-cell sarcoma, benign giant-cell sarcoma of the epulis type,

-

giant-cell sarcoid, giant-cell tumor (Bloodgood (12) , osteitis fibrosa cyslica
(von Recklinghausen), hemorrhagic osteomyelitis (Barrie (2), and osteoclastoma (32)(36).

The term most generally used today is giant-cell tumor or

giant-cell sarcoma of the epulis type.

Bloodgood (12) in 1912, after many

years of extensive study and analysis of the condition writes, "It is my
opinion that it might be well to drop Jhe term 'giant-cell sarcoma', as it
gives a wrong impression of the malignancy of the lesion, and use, at least
temporarily, the designation 'giant-cell tumor'."
the correctness of the term giant-cell sarcoma.

Mallory (64) also doubted
Stewart (86) disagrees with

Bloodgood who classifies them as benign giant-cell tumors, and also with Barrie
who characterizes them as a type of hemorrhagic osteomyelitis.

Stewart believes

that the name myeloid sarcoma, as introduced by Paget (73) nearly seventy years
ago, on account of the naked-eye resemblance of the tumor to red marrow, is
the best name to apply to this group of tumors; and that since none of its
constituent: cells is derived from specific bone marrow cells, the name "myeloma"
is inaccurate and should be dropped.

As it stands today, however, the majority

of authors are using the Bone Registry's Classification and refer to this
lesion as the benign giant-cell tumor of bone.

ETIOLOGY

O~

GIANT-CELL TUMOR

The question of the etiology of giant-cell tumors is at first glance
intricately interwoven with an academic question:

Is giant-cell tumor a neo-

plasm or a product of inflammation and repair? The acceptance of the name
giant-cell tumor as a substitute for all other names of this lesion is not
to be looked upon as a proof of the neoplastic nature of the lesion; the
term "tumor 11 is used here merely in a clinical sense, that is, to indicate
a swelling, inasmuch as the pathological anatomical sense of this word is
at present not entirely clarified.

The question of whether a giant-cell

tumor is a true blastoma or merely an inflammatory process follows an old
trodden path of discussion.

Alexander and Crawford (1) state that it has

at various times been considered the result of bone destruction due to
spirochaete, tuberculosis, infectious bacteria and parasites, trauma, malnutrition, and metabolic change.

As it stands today, the concept of the

disease known as giant-cell tumor divides investigators in two opposing
classes.

To one belong those who look upon

giant-ce~

tumor as a true

blastoma and to the other those who see in it merely a product of inflammation and repair in bone •. Kolodny (55) believes that since the view upon
giant-cell tumor as a true blastoma is supported by tradition, the burden
of proof in this dispute lies on the promulgators of the inflammatory nature
of giant-cell tumors.

The leaders among these are Mallory, Codman, and

Barrie in this country and Lubarsch and Konjetzny in Europe.

Mallory (64)

has long maintained that the giant cells of the giant-cell tumor are not an
integral part of the lesion but only a biological reaction of the large
mononuclears of the blood, the so-called endothelial leucocytes, which are
found wherever retrograde changes are going on.

As a reaction to calcium

salts absorption, these endothelial leucocytes fuse and form the giant cells.

6.
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Aside from these giant cells, no cells occur in these lesions which are not
met with in ordinary inflammatory processes.
Codman (21) sees in the giant-cell tumor a repair process following intra-osseous hemorrhages due to rupture of nutrient vessels.

In

Codman's opinion the tendency of this disease to form expansive tumors does
not warrant considering it as a neoplasm any more than does the enlargement
of an aneurysm.

Barrie (6) contends that the giant cells encountered in

these lesions must be disregarded in attempting to reach a decision whether
a process in bone should be considered either neoplastic or inflammatory,
from the microscopist•s angle of investigation.

"Such cells," he says,

"are the known accompaniment both of inflammation and neoplastic disease;
their presence, therefore, cannot be affirmative of tumor growth"
Early efforts at repair in any non-suppurative area of osteolysis
exhibits a picture similar to the process termed hemorrhagic osteomyelitis
or giant-cell tumor.

The same type of hemorrhagic granulation tissue struc-

ture is beautifully illustrated in early efforts at repair in fractures in
bone.

These facts, Barrie believes, should have weight against a diagnosis.

of neoplasm.
Steward (86) critically attacks Barrie's theory and emphasizes
that myeloid sarcoma {giant-cell tumor) is a specific tumor taking origin
from the fibrous tissue framework of the bone, and characterized by the
invariable presence of osteoclast-like giant cells in large numbers, the
latter being an integral and essential pa.rt of the tumor, making it unnecessary to assume that some foreign substance must be present to account
:tor them.

7.

ETIOLOGY OF GIANT-CELL TUMOR
Strongly substantiated by results of special investigations are
the opinions of Lubarsch (62) and Konjetzny (56).

Years ago Lubarsch had

pointed out that the new growths observed in the course of osteitis fibrosa
are of purely inflammatory nature.

On the side of histological preparations

Konjetzny showed how an intermedullary hemorrhage calls forth a reactive
proliferative process.

The product of this proliferative of the bone-marrow

which can be compared to granulation tissue, consists histologically of all
the elements encountered in lesions known as giant-cell tumor.

The clini-

cal course and the radiological findings are very closely related to those
of giant-cell tumors.

In the course of the natural life of this granulation

tissue there is a stage of differentiation when fibrous tissue, osteoid, and
sometimes osseous tissue takes the place of the hemorrhage after it has
subsided, the blood clot organized, and all the foreign elements removed.
Thus, Konjetzny concludes that the apparent tumor is merely a "chronic
resorptive process.tt
The opponents of the opinion that giant-cell tumors are true blasto-

m.ota emphasize the following points of the histology of giant-cell tumors
as supporting their views:

the absence of pleomorphism of the cellular

elements and of hyperchromatism of the nuclei and the absence of

exces~

of

mitoses; the differentiation of the cellular stroma into dense fibrous tissue
poor in cells; the uniformity in the size, shape, and chromatin content of
the giant cell nuclei; the relation of the giant cells to extravasations,
indicating their role in resorption; and the constant presence of old blood
pigment.

All these features are not inconsistent with the probabl.e inflamma-

tory nature of these lesions.

It is generally conceded

ho~

difficult it is

to distinguish histologically between a new growth in osteitis fibrosa and

8.
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,-_I

entirely independent lesions considered as giant-cell tumors.

This fact

alone is sutficient evidence to raise doubt as to the right by which giantcell tumor is occupying i.ts place in oncology.

On the other hand, there is

no sufficient evidence accumulated to support the contention that in all
cases of giant-cell tumor the lesion is a process of inflammation and repair.
The etiology of the typical giant-cell tumor is readily understood
if one accepts the new-growths observed in the course of osteitis fibrosa
cystica as giant-cell tumors.

The main complex of osteitis fibrosa is the

disappearance of haemotoblasts and fat cells from the bone-marrow with a
subsequent overgrowth of the fibrous stroma and lymphoid elements.

This is

accompanied by a simultaneous resorption of bone and new formation of osteoid
·:>!.

tissue, and this lead.a later in the course of years to fractures and deformities.

Frequently, in the course of the disease, one encounters for-

mation of cysts.

Hemorrhage into the cysts may lead to an overgrowth of

masses, resembling granulation tissue, which may enlarge and finally be
recognized as giant-cell tumors.

The frequent history of an antecedent mild

trauma in giant-cell tumors has led to the recognition of trauma as
portant etiological

an

im-

factor~

Barrie (6) reports that in all of

twenty~eight

elicit a history of recent or ancient trauma.

cases one could

Geschickter and Copeland (39)

on the grounds of embryologic observations show how trauma acts in producing the bone cyst and giant-cell tumor.

They maintain that trauma, in

disrupting the cortical blood supply produces an imbalance between osteoclastic proliferation in the medulla and relative compact bone in the cortex.
This osteoclastic activity to be of clinical significance, must be engrafted
upon a normal histogenic process.

It must be superimposed upon osteoclastic

ETIOLOGY OF GIANT-CELL TUMOR
resorption of calcified cartilage in the metaphysis in young patients to
cause a bone cyst, and upon a similar in the epiphysis in adults to produce
a giant-cell tumor.

That additional metabolic factors may enter into the

production of this imbalance is shown by the analysis of multiple giantcell tumors and bone cysts and the studies on the serum calcium and phosphorus in parathyroid disturbances.

The work of Jaffe has shown that in-

crease in parathyroid hormone alone does not produce true tumors of this
type although giant-cell areas and osteitis fibrosa-like tissue

may

be

formed in the bone in animals fed with an excess of this substance.

It is

apparent, however, from the studies recorded by Geschickter and Copeland
(39) that the age of the patient, the site of the injury, the rate and

extent of cartilagionous ossification at the end of the bone and the nature
of the blood supply in the affected regions are the predominant factors in
the development of bone cysts and giant-cell tumors.
Much depends upon the individual concept of trauma.
into the bone-marrow may lead to cyst formation.

Hemorrhage

Organization of the intra-

medullary hematoma with the appearance of the peculiar medullary granulation
tissue and expansion of the bone will then form the giant-cell tumor.

Very

· slight traumatization is frequently sufficient for the appearance of medullary
hematomata..

While it is usually thought that fractures are not the cause

but merely a complication of giant-cell tumor and osteitis fibrosa, it is
probable that fissure fractures or, better, infractions with the rupture of
nu~ient

vessels may lead to the formation of giant-cell tumor.

10.
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Kolodny (55) gives a most complete description of the anatomical
consideration of giant-cell tumors.

The gross anatomy of giant-cell tumors

depends largely upon the destructive and productive processes of the involved bone.

The tumor tissue during its period of growth constantly de-

stroys the bone while the periosteum lays down an advancing shell of new
bone, thus preventing the tumor mass from an early perforation of the bone
and an involvement of the adjoining structures.

It is due to a combination

of these two opposing reactions. of the involved bone that the giant-cell
tumor is an expansible but not infiltrative or invasive lesion encapsulated
in a bone shell.

Eating its way into the bone, the tumor tissue destroys

the bone from within the medullary cavity, gradually expanding the old cortex, while a few more or less thick bony trabeculae running in various
directions line the cystically expanded bone shell simulating beans,
supporting the whole struct:ure.

It is this structure that causes the most

characteristic "soap bubble" appearance in the roentgenogram.

The invest-

ing capsule of the giant-cell tumor is furnished_ by the new formed bone
shell and the periosteum.

Ewing (35) shows that with the increasing growth

of this reddish jelly-like tumor mass, the bony shell may eventually become
thin and allow passage of the tumor tissue, but there is seldom any tendency
toward invasion of the soft parts.

Long after the bone shell is thus per-

forated, the periosteum still continues to envelop the tumor until a very
advanced development of the tumor or a pathological fracture hastens the
perforation of the periosteal capsule.

This is in marked contrast to a

malignant bone tumor where the perforation of the bone and the periosteum
occurs very early.
The articular cartilage is very resistant in giant-cell tumor as
it is in osteogenic sarcoma.

It is most unusual to see the articular

GROSS PATHOLOGY

ll.

cartilage destroyed by tumor tissue even in the advanced stage.

An actual

direct involvement of the joint cavity by tumor tissue is even less frequent
than in osteogenic sarcoma; it occurs in pathological fracture and in very
advanced cases.

However, Gross (41) reported that the cartilaginous surfaces

of the joint may be reached and absorbed and the joint surfaces may collapse
from simple absorption, but without infiltration.
the joint

~~vity

Indirect involvement of

may occur by tumor tissue spreading along intra articular

ligaments, or from bone to bone along ligamentous attachments.
The gross

appearanc~

the phase of the lesion.

of the giant-cell tumor depends greatly upon

The typical giant-cell tumor consists of solid

portions and numerous small cysts.

The solid portions are very friable,

crumbly, somewhat granular masses, varying in color from yellow and light
brown to dark red.
tissue.

On incision, the tumor tends to extrude like granulation

The texture of the growth becomes more. dense with the approximation

to the periphery and capsule.

This vascular, soft, readily oozing, and

frequently profusely bleeding tumor, resembling currant jelly, is entirely
confined within the bone shell, it lies there loosely and can be easily
scooped out by a curette.

With the aging of the tumor or after radiation.

therapy, the tumor mass enters a cicatrizing phase.

The reddish jelly-like

tumor mass changes gradually, beginni.rig at the periphery, to a more opaque
and firm mass, while in the central portion the old juicy stroma prevails.
Some varieties of giant-cell tumors may be solid and firm throughout from
the commencement and because of their frequent peculiar yellow color due to
the presence of lipoid material, they have been designated as anthomata.
The various phases of giant-cell tumor are a result of advanced differentiation of the soft immature tumor tissue.
repair can be traced here.

All successive processes of

12.
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An attempt has been made to differentiate several varieties of

giant-cell tumors which differ from the typical tumor grossly as well as
histologically.

Xanthoma is designated a variant of giant-cell tumor in

which the presence of considerable fatty detritus lends the tumor a yellow
appearance.

Ewing (35) believes that the tumor may exhibit the features

of a myxoma or myxosarcoma, being more or less translucent and elastic.
It seems probable that the so-called m:yxomas of the marrow cavity have
mainly this origin (57).

The white giant-cell tumor is a rare but well

I

recognized variation.

Stewart (87) reports a case and in his discussion

states the sarcoma of bone , which are white in color, are almost invariably
highly malignant.

He, regards the maroon color as a secondary, even acci-

dental characteristic , due partly to increased vascularity and partly and more especially - to extravasation of blood.
While practically all the modern descriptions of myeloid sarcoma
insist on the constancy of this color characteristic, and only admit at most
that portions of the tumor may be white, Sir James Paget (73) in 1853 states
quite unequivocally that "the tumor may be all pale - .... - "·
tion reads:

His descrip-

"On section, the cut surfaces appear smooth, uniform, compact,

shining succulent, with a yellowish, not creamy fluid.

A peculiar appear-

ance is commonly given to these tumors by the cut surface presenting blotches
of dark or 11vid crimson, or of a brownish or a brighter blood colour, or of
a pale pink, or of all these tints mingled, on the greyish-white or greenish
colour basis.

The tumour may be all pa.le, or have only a few points of

ruddy blotching, or the cut surface may be nearly all suffused, or even the
whole substance may have a dull modena or crimson tinge, like the ruddy
colour of a heart or that of the parenchyma of the spleen."

13.
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Giant-cell tumors in whose texture islands of cartilage are encountered, are said to arise from absorption of misplaced islands of cartilage, when the released cartilage cells acquire a neoplastic character.
When the vascularity of the tumor is not confined to the central portion,
but is present in the largest partion of the tumor, it then represents the
telangiectatic variety of giant-cell tumor.

The clinical importance of

such a differentiation of variants of giant-cell tumor is questionable, since
there is no sufficient evidence accumulated to support the contention that
these variants differ greatly in their clinical course.

Furthermore, such

variants cannot be distinguished before the tumor is submitted for a patho-

.-...-,

r

logical examination, gross or histological.

The appearance of cysts in an

advanced giant-cell tumor is not uncommon.

This also occurs after radiation

therapy, where in the central portion extensive necrosis and cyst formation
filled with blood clot and serous fluid occurs.
The cysts are filled with blood or chocolate-colored fluid, or
an opaque, brownish, or greenish mucinous mass, a greenish or grayish serum,
evidently the product of various stages of decomposition of blood extravasations.

14.

MICROSCOPIC ANATOMY

Kolodny (55) reports that the histological structure of the typical
giant-cell tumor cohsists of two leading elements:
stroma.

the giant-cells, and the

The latter consists of numerous various sized blood spaces and

exceedingly thin walled capillaries suspended in a very loosely woven net
of spindle, round or polygonal cells with large vesicular nuclei.

One of

the most characteristic features of a giant-cell tumor is the absence of
pleomorphism of the cells of the stroma..

Geschickter and Copeland (39) re-

port that the round cells outnumber the spindle cells in every instance in
this typical tumor.

This small round cell has a relatively large nucleus

and a small amount of cytoplasm.
nucleolus.

.,,-....

There is a definite nuclear wall and a

There is, apparently, a definite relationship between the round

cell of the stroma and the giant cell.

In the first place, when the giant-

cells predominate in the tumor the round cell prevails in the stroma.

More-

over, the nuclei of the giant cell always have the same general form and
staining characteristics as the nuclei of the round cells.

The only impor-

tant variation is the tendency for the giant cells to have a more acidophilic cytoplasm with occasionally a greater concentration of chromatin in the
nuclei and other signs of early degeneration.

This could be accounted for

by the age of the giant cell, the inference being that the giant cells are
formed by agglutination of the round cells in the stroma

(~)

In the central portion of the tumor, fresh extravasations of blood
as well as hemosiderin can be found near the periphery of the bone shell.
Geschickter and Copeland (39) also report that red blood cells in a well
preserved state are scattered through the tumor more often
enclosed by endothelial walls.

unenc~osed

than

The typical giant-cell tumor is thus both

MICROSCOPIC ANATOMY
hemorrhagic and vascular, newly formed vessels being by no means rare.
Areas of organizing hemorrhage are frequent, and bordering on these is
loose edematous

t~ssue

intermingled with areas like those of osteitis fibrosa.

The giant cells average over 30 per field under the low power, with the number
of nuclei in each cell varying from fifteen to two hundred.

The cells range

in size from ten to one hundred microns and may or may not have distinct
borders to the cytoplasm.

Kolodny (55) states that the histogenesis of this

peculiar cell is still a subject of discussion; the theory in vogue at present is that these cells originate from the endothelium.

Barrie and his

associates (2,3,4,6,42) regard giant-cell tumors as a chronic, hemorrhagic,
non-suppurative osteomyelitis, probably of traumatic origin and consider that
the histological structure is indistinguishable from that of granulation
tissue and that the giant cells, of endothelial origin, are scavengers formed
for the purpose of absorbing and removing the detritus resulting from bone
destruction.
According to Mallory, there are two types of giant·cells, a tumor
giant-cell and a foreign body giant-cell.

The former are large, clear,

bladder-like cells, with distinct outline but staining faintly, within which
are multiple nuclei, which stain dreply and are situated in the center of
the cell.

They are true tumor cells resulting from multiple mitosis and

signify rapid growth.

The second type are as a rule smaller, their cyto-

plasm fairly abundant, sharply defined and staining deeply with acid dyes.
The nuclei are smaller, uniform, without mitosis, and are often in clusters
near the periphery of the cell.

They resemble osteoclasts and are merely

a reaction to the presence of foreign bodies and are due to the fusion of
endothelial leucocytes.

16.
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Stewart {86) agrees with Schafer (82) that the specialized fibrous
tissue framework also provides the multi nucleated osteoclasts, whose function is

bon~

absorption, and that they probably represent a specific form

of giant-cell.

Goforth (40) believes that two mesoblastic tissues, the

osteoblastic or osseous tissue proper, and the fibroblastic, or specialized
fibrous tissue framework intimately associated in bone structure, are the
elements composing giant-cell tumor.

Carnegie Dickson (31) and others,

think it probably arises from the reticulum of the marrow.

Kolliker (54)

and Gross (41) believe it originates from the osteoblast.

Jordan (50) who

has made a very careful study of this subject believes it may arise in either
of the last two ways.
lo conclusive work has been universally accepted as to whether the

l"""

giant cell is an integral part of the tumor, or as Barrie (3) believes, a
cell attracted to the tumor to remove the numerous particles present, due
to extensive disintegration.

Whatever opinion one may hold, one cannot deny

that the structure of a typical giant-cell tumor with the abundant giant
cells tied up like knots at the junctions of the endothelial strands suggests
that the giant cells play an important role in the composition of the tumor.
It is true that, when needed, the giant cells take up the function of scavengers and it is not uncommon to find, in giant cells, fatty detritus, remnants
of blood cells, blood pigment, and even small spicules of bone.
Geschickter and Copeland (39) are of the opinion that giant cells
with few nuclei, relatively small and sparsely distributed, are not typical
of the benign giant-cell tumor, but are more characteristic of osteitis
fibrosa and osteogenic sarcoma.

MICROSCOPIC ANATOMY

17.

Ewing (34), in describing the giant-cell tumor and its variants,
emphasized that a study of the stroma offers a standard for differentiating
between giant-cell tumor and medullary osteogenic sarcoma, secondarily containing giant cells, and is inclined to restrict the importance of the giant
cells themselves.
Spicules of bone, some undergoing destruction and others representing a healing reaction, are frequently found near the margin of the tumor or
its capsule.

Kolodny (55) believes that to avoid errors in diagnosing a

giant-cell tumor from the histology, one has to keep in mind the various
deviations. from the typical giant-cell tumor structure.

In the so-called

xanthoma, the resorption of a considerable amount of fatty detritus leads
to an impregnation of the phagocytozing cellular elements with lipoids.
Typical giant cells are few here, and their place is taken by aggregates of
endothelial leucocytes which are peculiar here because of the fairly granular cytoplasm resulting from the lipoid inclusions.
"foam cells".

These are the so-called

In the myxomatous type, the peripheral portion consists of

spindle cells, with a large chromatin content of the nuclei, embedded in a
mucinous mass.
The type of giant-cell tumor originating in connection with an
absorption of misplaced islands of cartilage, presents a marked deviation
from the normal structure.

Numerous imperfect cartilage cells are seen and

are called "epithelioid cells", because of their resemblance to epithelial
cells.

Unlike malignant bone tumors, in which the destruction of the in-

volved bone is accomplished by both osteoclasts and tumor cells, in giantcell tumors the task of destruction of the cortex is taken

ove:r~.by-

giant cells.

18.
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When a recurrence bas taken place in a giant-cell tumor, the histology shows a variable picture and is always of an altered character.
Cicatrization of a giant-cell tumor may be hastened occasionally by incomplete curretage and sometimes even by an exploratory incision, provided infaction does not set in.

Frequently, however, infection is not avoided and

the infected fungating pulsating masses of the tumor acquire an appearance
of a malignant new growth.

Histologically, such a giant-cell tumor is

greatly changed by the admixture of a reaction to infection and by stimulation to active grawth.
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The clinical incidence of giant-cell tumors is apparently lower than
that of primary JD&lignant bone tum.ors.

According to the report of Cod.man (21)

from the •terial or the Registry of Bone Sarcoma, the relative frequency or
giant-cell tumors as compared with malignant bone tumors is about 1:2.
Kolodny (55) believes this ratio is probably an exaggeration of the frequency
of giant-cell tumors, since the Registry material counts any eases in which
the patients were alive at the time the Registry began, while the average life
duration of a patient with a malignant bone tumor is about twenty months.

The

giant-cell tum.or is more frequently met with in the female than in 1he male;
the ratio 6:5 is probably a fair expression of this frequency.

Kolodny (55)

believes it is in the decade between sixteen and twenty-five that most giantcell tumors occur, an age considerably higher than for osteogenic sarcoma and
Ewing's sarcoma.

In 28% of females the disease occurred after the age of

thirty, as against 41% in males.
the oldest

~

man of sixty-eight.

The youngest patient was a girl of six, and
Platt (80) reports that over half or the

cases in his series have been patients in the fourth or even fifth decade of
life.

Dindeedn, he writes, Uthe Surprising incidence Of this tumor in the

middle aged occasionally leads to difficulties in the differential diagnosis
of solitary secondary malignant tumors of the long bones, where the primary
growth is laterit.

Geschickter and Copeland (39) report·tbat'forty per cent

of all cases are in the third

de~ade

of life.

Peirce (76) reporting the incidence of giant-cell tumors in the
last eight years from the University of Michigan, excluding involvement of
either maxilla or mandible, gives the age variation from four to forty-nine.

CLINICAL COURSE AID OCCURRENCE IN GI.ABT-CELL TUMORS
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There were two in the first decade, eight in the second, four in the third,
three in the fourth, and two in the fifth.

Of the nineteen cases, eleven were

male, eight femle.
The location of the giant-cell tumor is in marked contrast to that
of osteogenic sarcoma as far as the bone and the site of involvement is concerned.

The bones of the lower extremity were involved in 56% of all cases

of the Registry (21), While those of the upper extremity were involved in 23%
of all cases; in 21% of all cases the bones of the trunk, including the pelvis
and the shoulder girdle and the jaws, were involved.

or

all the cases of

involvement of the upper extremity, the radius was involved in 40%, all in
the lower end or the bone.

The femur was involved in 57% of all cases of

giant-cell tumor of the lower extremity and the tibia in 36%.

The lower end

of the femur was, as a rule, involv'd, with very few exceptions, when the
tumor was situated in the upper third of the femur about the troehanters.
The lower end of the femur is involved mu.ch more frequentl7 in the mle than
in the female, while an involvement of the upper end of the tibia, which is

three times as freqmnt as that of the lower end of this bone, is seen more
frequently in women than in men.

In general, in about

47% giant-cell tumors

were situated in the lower end of the femur and.the upper
The jaws were the seat of the tumor in about

~nd

of the tibia.

9% of all cases, the spine follow-

ing closel7 with 8% ot all cases of involvement.

Involvement of the jaws,

which is eqully distributed between the upper and lower jaw, is apparently
rare a£ter the age of 25.

The shaft of the long bones was involved in two

cases, while in both these cases there was place for doubt as to the accuracy
of the diagnosis, since a cyst complicated by a fracture could not be ruled
out.

Giant-cell tumor is situated in the smll bones ot the extremities more

CLINICAL COURSE AND OCCURRENCE IN GIANT-CELL TOJl)RS
frequently than osteogenic sarcoma.
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In contra,at with osteogenic sarcoma, in

which the epipbysis frequently escapes involvement because

.or

the epiphyseal

cartilage serving as a barrier to the spreading tumor, in giant-cell tumor the
epiphysis is involved in a large majority or cases.

Here the epipbyseal carti-

lage does not seem to exert any influence upon the spreading of the tumor and
the latter frequently extends from here into the diaphysis.

As a rule the

giant-cell tumor appears as a solitary lesion, and it would seem probable that
in some of the cases of multiple giant-cell tumors, one is dealing with a

proliferative osteitis fibrosa.
Alexander and Crawford (1), Kanavel (51), llartland and Haussling (42)
and Barrie (5) have reported what they have believed to be multiple giant-cell
tumors of bone.

In a recent communication from Crowell to Alexander and

Crawford (l) five additional cases are given which were presented to the
Registry of Bone Sarcoma.

It is interesting to note that no cases of multiple

giant-cell tumors have been accepted as true entities by the Committee on Bone
Sarcoma.

Codma.n, in communication with Alexander and Crawford (1) states that

he is skeptical about the existence of the condition.

Giant-cell tumors have

been found in almost every bone in the body.
Geschickter and Copeland (39) report from the records of the surgical
pathologic laboratory of the Johns Hopkins Hospital for a period of over thirtyfive years, only twenty-two cases

of

giant-cell tumor occurring in the head,

excluding the epulis of the alveolar border.

Two of the giant-cell tumors were

found in the temporal fossa, six are recorded in the upper, and fourteen in
the lower jaw.

All of these have been fomd in sites of bone formed from car-

tilage and none from the purely membranous portion of the calvarium (the
frontal and parietal bones).

Dean Lewis (60) in 1924 reported a case of primary

giant-cell tUJDOr of the vertebrae and reviewed sixteen cases from the literature.
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Cotton (27) in 1928 reported a similar case.

Kraft (57) described a

case or giant-cell tuaor or the patella and lie.thews (67), one of the clavicle.
The giant-cell.epulis of the jaws is quite frequently met with.

It is outside

of the scope or this paper to deal with them specifically and the reader is
referred to· excellent discussions by Geshickter and Copeland (39), Bloodgood
(11) and Scudder (83) for more detailed information regarding them.
Beekman (8), Broders (17), Garrett (37), and Ila.son and Woolston (66)
have recently reported cases or giant-cell tUJllors or the tendon sheath, and
emphasize the propensity for these tumors to occur on the hand about the
~ingers,

and on the foot and about the ankle.

Geschickter and Copeland (39)

.

support the view that the giant-cell tumor of the tendon sheaths arise in
the sesamoid bones.
The usual clinical history given by these patients has a sequence
of trauma, pain, tumor and fracture extending over a period of from two to
fourteen months.

Pain in these cases is usually more severe than in bone .

cysts, but of less severity than in osteogenic sarco•, of a more constant
nature, and is sufficient to cause disability.
Pain is frequent and early complained or by a patient afflicted
with giant-cell tumor.

The pain, however, is of less severity than in osteo-

genic sarco•, and it is more persistent after radiation therapy is begun.
The patient's general condition usually remains good unless an exploration
or incomplete curettage was done, accompanied by infection.

Infection is

very persistent in giant-cell tumor, and it may lead to sepsis in a brief
period of time.

The skin frequently lacks the dilated veins commonly seen

in osteogenic sarcoma.

When the skin is very distended by the large tumor,

it ma:y resemble pig skin, be edematous and cyanotic.

Ulceration or the skin
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occurs apparently only in the very far advanced cases which have long gone
without medical attention.

In the chapter on diagnosis I have discussed more

completely the physical_findings.
As a rule, giant-cell tumor is of long duration and slow growth;
notable exceptions are known, however.

At the present day, advanced stages

of giant-cell tumors are seldom seen since their growth is interrupted by
surgery or radiation.

Occasionally, in long standing tumors, attempts at

spontaneous healing occur, - cicatrization with ossification of the peripheric
portion and cyst formation in the center.
hemorrhage and sepsis may ensue.

When infection takes place fatal

After breaking through the investing cap-

sule, the tumor travels along the intermuscular and fascial planes but does

,,,,,....

not inve.de the muscle tissue.

Orthopedic problems arise from tumors of the

'

spine.

Infraction is almost a rule in giant-cell tumor, especially in the

weight-bearing

bo~es,

where also complete pathological fractures are frequent.

Geschickter and Copeland (39) report that pathologic fracture occurs in about

14%

of these cases, or about one third as often as in the bone cysts.

fact again emphasizes the necessity of splintering and recumbency.

This

The

pathological fracture of the lower extremity is usually of the telescoping
variety, with one end of the bone projecting into the cystically dilated
other end.

Joint involvement is exceedingly rare •.
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While some experienced observers maintain that it is always possible
to

arri~e

at a diagnosis in giant-cell tumor from a microscopic examination

of the section alone, and others claim that the clinical history together with
the physical findings and roentgen-ray features will suffice for diagnosis
without an exploration of the tumor.

Kolodny (55) believes that there are

times when neither method of examination, clinical and radiological, or microscopic, nor both of them combined will suffice for an accurate diagnosis.
These cases are rare, frequently they are complicated by previous surgical
treatment.

These are the cases referred to by Ewing (34) as the "borderline"

giant-cell tumors, with a wide destruction of bone, with an absence of bone
shell, with smaller than usual giant cells contaµ.ing larger and more hyperchromatic nuclei; they present a difficult task for the pathologist, especially
when diagnosis is requested from small curetted pieces of tissue.

Kolodny

(55) believes that to the careful observer a complete history and thorough

physical examination, supplemented by satisfactory roentgenograms, will suffice for an accurate diagnosis in the majority of cases.

According to

Kolodny (55) palpation is an important diagnostic aid in the examination of
a giant-cell tumor.

Frequently, one is able to palpate the bony capsule of

the tumor and its bbrders at the junction with the uninvolved diaph.ysis.

..

The

bulky spheric shape feel of the tumor contrasts it from the fusj.form shape
of the osteogenic sarcoma.

It is much easier to palpate in giant-cell tumors

because of relative absence of tenderness.

When the bone shell of the tumor

becomes very thin, egg-shell crackling can be made out.

In the very vascular

variety of giant-cell tumors one occasionally feels a bruit.
Herendeen (44) believes that the location of the tumor is one of the
most important points in the diagnosis of giant-cell tumors.

Although they

'\'
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may

occur in any-bone in the body (they have been found in the skull,

vertebrae, ribs, pelvis, upper end of femur and humerus, lower end of the
ulna and radius, tibia and fibula), the most common sites are in the ends
o; the bones at the knee joints, and a tumor in the medullary portion of the
distal end of the radium is nine times out of ten a giant-cell tumor.

Giant-

cell tumors may occur in the shaft or at some distance away from the end of · ,
the bone, but in these instances the diagnosis is more uncertain and the
chances are greater that the tumor is a malignant one, as purely benign proceases, other than giant-cell tumors such as chondromas and cysts in the
medulla of bones are comparatively rare.
Morton and Duffy (69) of Yale University :Medical School published an
article on Bone Sarcoma in which they stated:

"We are impressed with the

difficulties which confront the average surgeon in arriving at a correct
diagnosis and in deciding on proper treatment in any group of bone tumors.
There are so many exceptions to the rule, that each case must be most completely studied and weighed before action is taken.

Were we to trust to the

Rontgen-ray picture for diagnosis we would in many instances be wrong.
we to depend upon the microscopic

se~tions

Were

-

alone, especially at the time of

operation, we would be often misled. "
Robert Osgood and his collaborators (72), in an editorial note following a review of Tumors of Bones, say :

"Differential diagnosis of bone

tumors is far from certain by any known method, particularly rontgenoscopy.
This is altogether natural when we remember that even with the gross specimen
before him and the slide under the microscope, the pathologist is often un~

certain as to its character.

Often there is such widespread involvement of

the bone that it is impossible to determine the point of origin or the invasion.

While in sympathy with any effort to systematize the diagnosis, we

are under the impression that the one point of importance is whether the

-
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growth is benign or malignant, and that the best way to determine this is by
immediate exploration and pathologic examination.

The relation of the region

to be examined is also of importance, and occasionally the surgeon well trained
in gross appearances in malignant disease must be governed by his finding quite
as much as by the report of the pathologist, made necessarily somewhat incompletely at the time of operation."
Bost (16), in an excellent article on differential diagnosis, writes
that giant-cell tumor must be differentiated from the following single osteolytic bone tumors:

(1) bone cyst, {2) osteolytic sarcoma, (3) Brodie's

abscess, (4) chondroma, {5) latent bone cyst, (6) sihgle metastatic tumors,

-

and (7) osteitis fibrosa cystica.
osteomyelitis and tuberculosis.

It must also be differentiated from latent
Bone cysts involve mainly the diaphyses of

the long bones and occur in the early epiphyseal age, from 5 to 15 years of
age, and most often in the upper humerus, lower tibia, and upper femur.
t~mor

expands the bone only slightly.

This

The cortex of the bone at both ends

of the cyst is thinned out so that there is a gradual thinning of the cortex
from the middle of the cyst to the poles, and not the abrupt transition of
the normal cortex frequently seen in giant-cell tumor.
Osteolytic sarcoma is a malignant tumor occurring in patients from
10 to 20 years of age and involving the upper tibia, lower femur, and upper
humerus.

The point of differential diagnosis in this tumor is the fact that

the tumor is medullary and rapidly destroys the cortex without expansion.
This differentiates these tumors from benign lesions.
Brodies abscess may

rese~ble

a giant-cell tumor, but as a rule this

condition involves the shaft of a long bone with no expansion or destruction
of the cortex.

-
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Chondroma may resemble a giant-cell tumor.

However, these growths

usually occur in the phalanges of the hands and feet, and in the sternum,
where the

giant~cell

tumors rarely occur.

Latent bone cyst originates at any age, and is usually discovered
aecidentaly in the third decade.

This cystic disease differs very little

from the usual bone cyst, except that the condition has existed from childhood, being in a quiescent state without extension of the process.
Metastatic carcinoma to bone should rarely be confused with giantcell tumor.

It usually occurs in the bone near the nutrient artery, the mid-

portion of the bone.
of its expansion.

.-

The cortex is entirely destroyed without any evidence

Metastatic carcinoma occurs usually after the age of 40,

and more frequently in females.

The disease is rare in bones below the elbows

or the knees.
The benign giant-cell tumor may at times simulate a la.tent osteomyeli tis.

In these cases, a complete clinical history is of greatest value, and

should always be secured in cases of doubtful diagnosis.
Tuberculosis gives a fairly definite clinical history.

Joint involve-

ment with subsequent disability is always an early feature, whereas in giantcell tumor the joint is not usually involved.
always late in the history of the case.

this does occur, it is

~ben

The distinguishing factor is that in

giant-cell tumor the enlargement is asymmetrical, whereas in tuberculosis there
is symmetrical enlargement.
Osteitis fibrosa cystica with bone destruction and thinning of the
cortex often resembles giant-cell tumor.
_

However, in

oste~tis

fibrosa cystica

we find no expansion of the cortex, so typical of giant-cell tumor.

Giant-

cell tumor involves the epiphysis after ossification, while osteitis fibrosa
cystica is present in the shaft of the bone before

ossifica~ion.

·-
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Early osteogenic sarcoma may at times be difficult to distinguish from
giant-cell tumor.

However, giant cell tumor is always present in the epiphy-

seal area of the bone.

New bone is produced in osteogenic sarcoma and is laid

down in radiating lines perpendicular to the shaft, whereas new bone is never
produced in giant-cell tumor.
Radiological examination is of outstanding diagnostic importance.
Repeated radiological examination of skeletal tumors from many angles is indispensable for an accurate diagnosis.

The roentgenogram is frequently of

more importance than a microscopic examination when a variant of giant-cell
tumor is dealt with.
The radiological appearance of a giant-cell tumor is most characteristic.

It usually casts a bulky spherical shadow, showing a_multicystic

appearance as a result of the osseous trabeculation in the periphery.

The

shaft of the bone is absent and it appears as if the cortex is blown out from
within the medullary cavity so as to form the thin bone shell, which sharply
limits the tumor from the surrounding soft tissues.

A continuation of the

bone shell is seen limiting the tumor from the adjoining unaffected medullary
cavity.

When in advanced cases of giant-cell tumor, the bone shell is de-

stroyed, in some areas the roentgenogram will simulate an invasion of the
tumor into the soft tissues in spite of the intact periosteum.
not confuse the reader from diagnosing giant-cell tumor.

This should

When the adjoining

periosteum and cortex remain unaffected, this points strongly against osteogenic sarcoma.

-

The shaft is absent in giant-cell tumor, but may be seen

running through the osteogenic sarcoma.

In giant-cell tumor, the tumor is

in direct contact with the articular cartilage, while in osteogenic sarcoma a
thin layer of spongiosa remains between the tumor and the cartilage.

DIAGNOSIS
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Nichols (71) in an endeavor to simplify the roentgenologic diagnosis
of bone tumors suggests a differential method based on the observation of four
fundamental points:

(1) their origin, whether medullary or cortical; (2)

whether or not they are characterized by bone production, by bone destruction,
or both; (3) the resultant condition of the cortex, whether expanded or destroyed, and (4) whether the growth is invasive or non-invasive.
When combined with the clinical history, physical findings and radiological features, the data of a pathological examination are of valuable
diagnostic importance.

To one experienced in the pathology of bone tumors,

the gross anatomy of a giant-cell tumor will frequently mean more than the
histology.

-

It is well to remember that an occasional tumor can resemble

grossly or histologically a giant-cell tumor and not be one,

The histology is

frequently misleading in giant-cell tumor, especfally so when e frozen section
is relied upon, as often happens.

The diagnosis of giant-cell tumor from the

section must not be based upon the presence of giant-cells alone; the type of
supporting tissue is most important, although the giant cells are said to be
an integral part of the giant-cell tumor they are occasionally encountered
also in typical osteogenic sarcoma where lime salts are set free by rapid
erosion and disintegration of bone.

The very vascular, so-called telangiec-

tatic osteogenic sarcoma may resemble grossly vascular giant-cell tumor.
histology is often misleading in the variants of giant-cell tumor.

The

In the

rnyxomatous variation the histology may suggest malignancy while the clinical
findings e.nd radiological features clearly indicate the benign nature of the
lesion.
.-

In cartilaginous giant-cell tumors in a few cases a diagnosis of

myelome. has been returned by the pathologist because of the abundance of
rounded cells of the stroma.

Occasionally several varibnts may be found in

-
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the same tumor.

The histology is especia.lly deceiving when the tissues are

taken from tumor masses fungating through a former exploratory incision.
Shall a biopsy be performed before any method of treatment is adopted?
Upon this point there is the widest variance of opinion.

It wuuld seem that

the whole question is merely a part of the general advisability of a biopsy
in bone tumors of doubtful nature, since the necessity of exploration indicates
that one is not certain whether the tumor is benign or malignant.

The diffi-

culties encountered in a diagnosis from the histology in a doubtful giant-cell
tumor are great to those little initiated in the pathology of bone tumors.
Ewing (34) repeatedly stresses the importance or desirability of making a
diagnosis without biopsy.

Kolodny (55) P.elieves that as a general rule, when

the clinical findings and the roentgenogram are barfling to the clinician,
the histology is also distressing to the pathologist.

Whatever one may say

about the increase of malignancy in giant-cell tumors, by an exploratory
incision, one cannot deny that the dangers of infection with which such explorations are entailed are very great.

However, if a biopsy is done, the

curettage of the tumor should be completed because a following infection will
add greatly, to the difficulties of radiation.
Bloodgood (14) suggests the following working rule for the diagnosis
and treatment of tumors of bone.

If a patient is under ·fifteen years, it is

probable that sarcoma is not present, and the diagnosis rests between the
common bone cyst, the less frequent giant-cell tumor and the rare chondromy:xoma.

If the patient is over fifteen, sarcoma cannot be excluded.

most common central lesion of bone is the benign bone cyst.
cases, they recover without any treatment.
which predominates in patients over fifteen.

The

In the majority r:f

The second is the giant-cell tumor,
Myxoma may occur at any age.
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Myxoma must be constantly borne in mind, and is the most difficult of all bone
tumors to eradicate locally.
The location of the tumor is also important:

whether in the end of the

bone, in the joint, or in the middle of the bone near the nutrient foramen;
the last being the favorite site of the metastasizing carcinoma.

Malignant

tumors do not cross a joint, so that a lesion involving both sides of the joint
is always a benign process.

Whether the tumor is single or multiple, is also

important, as is also the age of the patient.
Geschickter and Copeland (39) are of the opinion that the adult age
of the patient and the involvement of an epiphysis are the most important aids
in making a differential diagnosis.

The other common central bone destructive

lesion occurring in an adult is a single focus of metastatic carcinoma.
I~

Bost (16) believes that giant-cell tumor may often be positively diagnosed by the roentgen findings, but not always.

He presents the following

characteristics of giant-cell tumors from the roentgenologic standpoint:
(1) the lesion is subcortical, beginning at one side of the epiphysis and
gradually extending centrally, involving cancellous bone; (2) the lesion is
almost always invariably single; (3) it is an epiphyseal disease, the lesions
involving most frequently the upper end of the tibia, lower femur, and lower
radius; (4) the tumor occurs usually between the ages of twenty and thirty
years; (5) the tumor appears in the roentgenogram as a circumscribed bone destructive lesion, involving the epiphysis and diaphysis, the tumor being
globular, trabeculated, and asymmetrical; (6) the growth is medullary, and of
osteolytic character; (7) giant-cell tumor arises only in bone derived from
~

cartilage, a fact which gives these tumors their characteristic location and
age distribution.
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Barrie (6) presents the following table covering the more important
features pertaining to the solitary lesion in making a diagnosis of hemorr-

•

hagic osteomyelitis {giant-cell tumor):
Clinical Picture
Age of Patient - May occur at any age.

Most frequent in first and

second decades of life.
Duration of Lesion - Months - perhaps years before lesion attains
large size.
Symptoms of Onset - Usually history of injury, recent or remote.
Pain

-

Inspection
Palpation

- Apparently never constant.
- Usually some enlargement of site of lesion.

-

- Tenderness and pain on pressure.

Joint movements Some limitation of motion in nearest joint.

Limp

with lesion in lower extremity.

X-RAY PATHOLOGY
Cancelli

- - Area of osteolysis rather clear cut, rounded or
oval in shape.

Periosteum -

- Usually intact unless lesion has attained large
size, years after onset.

Gross Pathology Appearance of vascular granulation tissue sometimes
interspersed with areas of fibrosis, or degenerated
hyaline masses.
Microscopic Picture - Heterogeneous cellular picture of fibroblasts,
scavenger giant-cells, endothelial and polynuclear
leucocytes, lymphocytes, eosinophiles and red blood
cells.
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The theory that giant-cell sarcoma is always a benign lesion and
never metastasizes dates back to the middle of the nineteenth century.

In

1854 Sir James Paget (74), in his lecture on surgical pathology, gave Lebert
full credit ror being the first one to describe giant-cell tumors.

After a

stug.y of Lebert' s cases, as well as a few of his own, Paget very modestly
concludes that his own observations are too rew and too various to warrant
many general conclusions.

Those which he tentatively expressed, however,

were:
"The tumor is single, occurs most frequently ih youth, rarely in adult
age, is slow in growth, and without pain, and generally comes on without
any known cause such as injury; has no tendency to ulcerate. - - -

"47 (but I suppose very rarely) cease to grow.

They

They are not apt to recur

after complete removal, nor have they in general any features of malignant
disease."
And then, at the end, Paget very wisely adds, that while these and many other
cases may be enough to prove that the myeloid tumors (giant-cell tumors) are
generally of an innocent nature, "still, I suppose, cases may be found in
which, with the same apparent structure, a malignant course is run." Further
observations have shown some of Paget's conclusions to be incorrect.

It is

now known that injury is a very important factor as an exciting cause.
Coley (24) reports that fifty-six per cent of his series of cases gives a
distinct history of antecedent local injury, and also that pain is one of
the earliest and most constant symptom.
Nelaton, in 1860, strongly advocated the view that giant-cell tumors
are only locally malignant, and furnishing much new data in support of this
view.

,.....
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I

Bloodgood (10,12,13) for Jl8DY' years has upheld this doctrine and at
present the majority of pathologists here and in Europe have accepted it.
Coley (24) states that, "This view has been expressed so often and so emphatically that Jll8JlT surgeons have accepted. it without a sufficiently caretul or critical examination of the data upon which it is founded."

Only in

the light of data accumulated from the clinical history, physical and radio- logical findings and pathological exa•ination may a prognosis be given.
When left alone, the giant-cell tumor may follow one of two wa7s.
_ Advanced growth of the tumor may lead to fatal he•orrhage or septicemia.
Occasionall7, following a pathological fracture, slJC)l a tumor may enter a
cicatrizing stage.

The bony- shell may become very thick.

The question of the prognosis of giant-cell tumor treated conserv•
tively by curettage or radiation, for.a a subject for ardent discussion.
On one side many cases are cited of giant-cell tumor leading to pulmonary
metastases, and death.

Kolodny (55) reveals two sources of error of these

authors by a careful study of their cases.

The first is that not in all

cases mentioned was the primary- lesion a giant-cell tumor, and the second
that not in all fatal cases are metastases proved to have been present.

On

the other hand, the authors believe that giant-cell tumors are always benign
lesions lacking the ability to produce metastases.

The exceedingly few cases

of giant-cell tumor in which, after repeated surgical operations, pulmon&r7
me~stases

and death occurred these authors explain by the fact that due to

surgical insult and ill-advised therapeutic measures the giant-cell tumor
becomes transfor.ed into a malignant bone tumor which, as a malignant tumor
and not as a giant-cell tumor, led to pulmonary metastases.
Gross (41} in 1879, for the first time, reported five cases of benign giant-cell tumors which underwent degeneration.

From this time on,

35.

PROGNOSIS

the question of benignity.or malignancy of the giant-cell tumor led to some
of the most passionate disputes ever known in medical literature.

Thus,

while Bryant (18), Bloodgood (13, 15), Martland (65), Stone and Ewing (89)
Codman (20) and Meyerding (68) and others, considered the benign character
of the lesion as unquestionable, Stewart ( 88) , Waugh and Turner ( 90) ,
Shattock (84), MacGuire and McWhorter (63), Finch and Gleave (36), King (52)
and especially Coley (24) repeatedly emphasized that some of the giant-cell
tumors are distinctly malignant and that they produce metastases.
the Registry could settle the question definitely.

Not even

While Codman (20) is

"convinced that they are benign", Kolodny (55) after analyzing the same
material says:

11

The question as it stands today is whether or not a giant-

cell tumor is always benign.

From the evidence on hand, this question is

to be answered in the negative."

At the same time Goforth (40) writes:

"Giant-cell tumors constitute a series.

Those at the lower end of the scale

show relatively adult fibrous stromas·, and are essentially benign.

They

exhibit more cellular and active stromas, composed chiefly of relatively
immature fibroblasts cells, and become increasingly more locally aggressive
as the scale is ascended."
Evans and Leucutia (33) believe the giant-cell tumor is essentially
benign, but believe that such a differentiation as that of Goforth is of some
help from the therapeutic standpoint.

It is comprehensible that a rather

cellular tumor with immature fibroblastic elements would show a great tendency toward recurrence, especially if incompletely removed.

Moreover, since

with each recurrence, the tumor is apt to become more and more virulent, it
~

is plausible that finally a malignant degeneration of the lesion should follow.
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Stone and Ewing (89) described such a case.

Evans and Leucutia (33)

believe that the majority of eases described in the literature as primarily
malignant giant-cell tumors are based on mistaken or incomplete diagnosies.

Dr. Channing Simmons (85), in analyzing the cases of the Registry, concludes
that there is no instance in which a proved giant-cell tumor formed metastases.
He cites cases 295, 349 and 68 to show that the giant-cell tumor may change
its character and become osteogenic sarcoma which metastasize in the usual
manner and causes death.

He states that giant-cell tumor is known to become

an osteogenic sarcoma in about 3.7% of the cases.

Crowell, (29) in present-

ing the 1933 report on the Registry of Bone Sarcoma, lists 272 cases of
benign giant-cell tumor, and 14 cases of malignant giant-caµ tumor.
The main factor in the clinical course of giant-cell tumor requiring
one to be on guard in the prognosis is rapid growth of the tumor.
giant-cell tumor is of long duration and slow course.
is a sign of aggressiveness of the tumor.

The typical

Rapidity of growth

Another reliable sign of aggress-

iveness is the destruction of a large portion of the bone shell of the tumor.
A giant-cell tumor reaching a very large size is very apt to recur after
curettage since the size of the tumor excludes the possibility of a complete
removal of the tumor tissue.
less favorable.

With each recurrence the prognosis becomes

Care should be exercised in the arrival at a prognosis based

upon a recurrence, because with each recurrence the growth is apt to become
more anaplastic and malignant.

The high percentage of clinical recurrences

after treatment in typical giant-cell tumor spaalts for the progressive nature
of this disease.

Geschickter and Copeland (38) reviewed 222 cases of giant-

cell tumor in the surgical pathological laboratory of Johns Hopkins Hospital
and f o\Dld that there were thirty-one recurrent cases following a primary
curettement, and many of these showed repeated recurrences despite surgical
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intervention.

Recurrence was found to depend not on histologic structure,

but on a poor selection in the type of treatment applied in the individual
case or on an incomplete operation.

Advanced destruction of the bone shell,

incomplete currettement, failure to use chemical or thermal cauterization
or needless sacrifice of cortical bone at the operation. as well as an age
QVer 35, were found to be factors predisposing to recurrence after curettement.
In relation to a prognosis, the findings of a pathological examination are of outstanding significance.

The giant-cells of epulis type, when

present in excess, are a true indication of the benignity of the lesion.

The

typical giant-cell tUJDor where the giant cells form the bulk of the tumor is
of very slow growth, not aggressive, and easily eradicated even by incomplete
curettage.

On the other hand, with the disappearance of the giant cells and

with an increase in the number of spindle cells of the stroma, the aggressiveness of the tumor increases.

Viewed largely, the type of cells of the stroma

are of greater importance than the giant cells.

Recurrence can be expected

when the hyperchro.matism of the stroma cells occurs and also when the stroma
cells have become abundant and rounded.

However, pleomorphism and cellu-

larity in tlle central portion of a giant-cell tumor are not of such unfavorable significance for the prognosis as their presence in the peripheric
portion or the tumor, where they notoriously mark aggressiveness.

A guarded

prognosis is to be given also in the case of the very vascular, so-called
telangiectatic, giant-cell tumor which as a rule is more aggressive and
recurs more frequently than other types.
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While in :malignant bone tumors the problem of therapy today is to
find a way to relieve the sufferings of the patient for a longer period of
time, in giant-cell t'UJllOr, the whole crux of the question is as to choice
between various methods of treatment, each of which may lead to permanent
cure.

The history of the therapy of giant-cell tumor is remarkable for the

continuous change from radical to more conservative methods of' treatment.
Bryant (19) reports a case of a young woman treated in 1861 by
amputation of' the thigh who was still alive after seventeen years.

Dr.

Gross (41) in 1879 treated these tumors by amputation when permitted, and
occasionally excised when the more radical measures were refused.

He con-

eluded that although surgical interference was followed by a mortality of
31.25%, it frequently succeeded in preventing local and systemic infection
as well as prolonging life.

He was of the opinion that because of the diffi:-

culty in determining the true nature of' the neoplasm in its incipient stages,
delays were' extremely dangerous, s-i.nce, instead of having to deal with pure
Dtifeloid sarcoma (giant-cell tumor), the disease might eventually prove to be
an osteoid sarcoma, or a small celled medullary sarcoma, in which events,
valuable time would have been lost, and the patients would have been exposed
to the dangers of local infection and general dissemination.

Inste~d

of am-

putation, excision bf an entire joint, or of the affected epiphysis, along
with the shaft, of the more slender long bones were resorted to, particularly
if the tumor presented a uniformly smooth surface, and was of a firm, dense
consistence or was enclosed in an osseous shell.

In cases of doubt, excision

was commenced, and removal of the limb was substituted, i f the capsule of the
tumor was discovered to be perforated, and the sgft parts infiltrated by the
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morbid product.
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The mortality rates were high because of the profuse hemorr-

bage encountered near the seat of the tumor, the high percentage of postoperative infections, and the number of malignant sarcomas which were diagnosed
as myeloid sarcomas (giant-cell tumors) with death ensuing from subsequent
lung metastasis.

Towards the end of the ninteenth century the benign nature

of the giant-cell tumor became more widely accepted and the more conservative
resection method gained its group of supporters, headed by Dre. v.Bergmann,
Mickulicz and v.Bramann (9).

Hinds (47) in 1898 reported a case of myeloid

sarcoma (giant-cell tumor) of the femur treated by scraping.
and firm growth was scraped out with a sharp spoon.

The dark red

The surface of the cavity

was scrubbed with chloride of zinc solution (grains twenty to the ounce), and
was packed with cyanide gauze.

At the end of six weeks, because of unsatis-

factory granulations, the cavity was again scraped out and scrubbed with
zinc chloride solution.

The patient made an uneventful recovery and was in

excellent general health 1 with a slight deformity of the knee, after a period
of three years.

In 1916 Dr. Hinds (13) 1n a personal communication to Dr.

Bloodgood enclosed a letter from the patient written twenty-one years after
conservative operation.

The patient had perfect function and worked as a

forester cutting down trees, carrying heavy weights, and walking from ten to
twelve miles a day.

An x-ray print (12) was also sent, demonstrating that

the cavity was filled with bone. Dr. Bloodgood (10), 1n 1903, reported a case
of a medullary giant-cell sarcoma (giant-cell tlDllor) of the upper end of
the tibia in which the tumor was apparently completely removed by chiselling
without destroying the continuity of the tibia.

The entire bone cavity was

curetted and swabbed with pure carbolic acid, followed by alcohol, then
irrigated with 1:1000 bichloride solution, followed by normal salt solution.

40.

TREATMENT

Horsely's wax was used to check the bleeding in the cavity.

The patient was

in good health and almost complete function was restored in 1903 - one and
one half years later.
In 1891 the curative effect of accidental erysipelas in inoperable
sarcoma was observed by Dr. Coley (22).

In 1893 he began the use of toxins

of erysipelas and Bacillus prodigiosus in the treatment of inoperable bone
sarcoma, and s.oon after that used them in operable cases as a prophylactic
against recurrence, after amputation.

He reported in 1909 the successful

use of the mixed toxins in 52 cases of inoperable sarcoma.

With such ex-

cellent results in inoperable cases, the mixed toxins of erysipelas and
Bacillus prodigiosus were used as an adjunct to treatment with gratifying
results.

Dr. Coley ( 23) says, regarding the use of mixed toxins in the more

benign lesions of bone,"while good results have been obtained from operation
alone in a limited number of cases in this group,

;r

am convinced that the

number of successes will be greatly increased by qombining the toxin treatment with conservative operation".

Dr. Bloodgood (12) agrees with». Coley

that his serum should be used in all inoperable

c~ses,

that it should also

be used before and after operable cases when the ~arcoma is of a type which
experience has shown to be very malignant, and in iwhich few, if any, cures
have been accomplished.

He cites twenty-six

case~

which there was no treatment other than removal

o~

of giant-cell tumor in
the tumor by curette,

excision, resection, or amputation, and in no case was there a recurrence or
metastasis of the disease.

He is of the opinion ~hat there is no more reason

for giving a patient with a true giant-cell tumor jcoley' s serum, x-ray, o:;
i

radium treatment, than to employ them for lipoma., lexostosis or any other type
of benign tumor.

!

Bloodgood's (12) conclusions as !to the conservative

treatment are as follows:
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1. Conservative treatment is justifiable.

Curetting should in

some localizations of the tumor, be the operation of choice.

But in those

localizations where resection in continuity does not interfere with function, resection becomes the operation of choice; for example, upper end of
fibula, lower end of ulna.
2. It is justifiable to attempt curetting to preserve function
even when conditions suggest a great probability of recurrence.

There is

no position where curetting is not justifiable as a first attempt.

It has

succeeded when the entire lower end of the femur was involved.

3.

The number of successful cases of curetting will depend chiefly

on the number of attempts.

4. After curetting or resection, the wound should be disinfected
with pure carbolic acid followed by alcohol or chloride of zinc solution.
Thermal cauterization may replace chemical cauterization.
should always be done, if possible, under an Esmarch.

The operation

This procedure is not

indicated because of the malignancy of the giant-cell tumor, but because in
curetting disseminated cells are left, while in resection, cutting into the
tumor may inadvertently be done. qf FI
t
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LEI bl*/ Hitzrot (48) states that recurrences have been more frequent

when this

h~s

been incomplete or has not been followed by cauterization.

5. It is not necessary to perform the bone transplantation at the
primary operation unless a single bone like the humerus or femur is divided
in its continuity.

In simple cases there is no reason why the transplanta-

tion should not be performed at the same time, but in some cases the resection
may be tedious and bloody, and the patient may not be in good condition.
such cases it will be safer to transplant at a second operation.

In
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6. It is simpler, when possible, to get the bone for filling the
defect by splitting the bone which has been resected.

This can be accom-

plished through a single wound. When this cannot be done on account of a
large defect, one can remove the upper third of the fibula without injury
to the function of the limb, or chisel large pieces from the tibia without
destroying the continuity of the bone'? The treatment of giant-cell tumors
of bone by means of the roentgen ray covers a period of at least twenty-five
years.

Dr. Pfahler (78) in 1906 was the first to treat such a case.

roentgenological diagnosis of osteo-sarcoma was made.

A section removed for

microscopical examihation was diagnosed as a round cell sarcoma.
1

A

The patient

was given intense roentgen ray treatment and was symptom free after three
months.

After a year and a half the bony tumor was only reduced to two thirds

of its original size.

This was reported as "the first case that has been

observed Roentgenologically during the process of recovery from an osteosarcoma".

Dr. Pfahler (79) reviewed this case in 1932 and reported that,

"it showed begjnning lime deposit at.. the end of a month, and progressive
improvement from that time onward, during at least fifteen years, and is
known to be well for twenty-five years.

At the end of this time the bone

completely recalcified but remained about 25% larger than normal".

The clin-

ical, roentgenological, and microscopical diagnosis was "sarcoma", but in
retrospect these "cured sarcoma.ta" are now recognized as having been giantcell tumors.

Dr. Herendeen (43)

in

1924 wrote his first of a series of articles

dealing with the roentgen-ray treatment of bone tumors, recording the changes
noted in giant-cell tumors following treatment with the roentgen ray or
radium, and comparing briefly the value of these agents with the standard
surgical methods of treatment.

43.
The cases treated at the Memorial Hospital from 1919 to 1924 were
grouped as follows:
was performed.

Group I, consisted or those cases in which no operation

(In two or three instances incision for biopsy was done.)

Group II, consisted of those cases referred for treatment on account of recurrence following operation.

Group III, consisted of those cases referred

for treatment to pPevent recurrence after operation.

In the majority or the

cases representing Group I, the roentgenographic features were so characteristic that the diagnosis was made without the aid of a biopsy.

The changes

observed, following treatment, were largely in those cases in which there
had been no incision into the tumor.

In addition to the cases in Group I,

seven cases were treated on account of a recurrence and five to prevent recurrence after curettage.
These figures emphasize two things:

of the cases of giant-cell

tuaor admitted to the hospital, about 15% applied for treatment to prevent
recurrence, on advice of their surgeons, who apparently realize the difficulty of removing all of the tumor tissue; about 20% applied for treatment
for a recurrence - some cases having a recurrence after two or three curetteaents or attempt at local removal.

Plates made from one to two months

following treatment have revealed in almost every case the same reaction,
which consists in rapid enlargement of the tumor, with expansion or the
cortex and a thinning out of the bony capsule or the tumor, until hardly any
of the outline is visible.

Prior to the demonstration of these changes in

the roentgenogram, the skin becomes reddened-, and the parts swollen and soft
or edematous to the touch.

As time goes on the redness and swelling subside,

the tumor becoaes firm to the touch, and a roentgenogram then reveals a return of the outline of the tumor, with evidence of the production of bone or
deposit of calcium in its capsule.

The function of the part returns, pain

TREATMENT

44.

disappears, and the tumor feels firm or stony hard.

A plate made later dis-

closes increasing densit7 and calcification, and later still the entire mass
seems converted into almost solid bone.
During the stage of reaction - that is, a month or two after the
first treatment is given - the tumor has all the appearance, both clinically
and roentgenographically, of a rapid increase in growth.

Most surgeons and

others unfamiliar with the changes induced by the roentgen-ray treatment,
assert that it is a failure, and the assertion is also made that it stimulates
the activity of the growth, hence immediate operation is advised.

If, how-

ever, at the end of another month or two., the patient is examined and a roentgenogram is made, it will be found that the reaction has subsided, that the
tumor is becoming ossified, that pain is relieved and function is returning,
and there is present a well-marked effort of a healing process.

Up to the

time of the writing of this article by Herendeen, sixteen cases of primary
giant-cell tumor of the bone had been treated at the Memorial Hospital with
the roentgen-ray or radium alone.
the Registry for Bone Sarcomas.
apparently cured in 1924.

All of these cases were filed at Boston in
The oldest case was treated in 1918 and was

Eight of the thirty-six cases studied were classi-

fied as a typical, undetermined, or as tumors simulating giant-cell tumors.
This figure emphasizes the frequency with which one encounters variations from
the typical or characteristic giant-cell tumors.

Herendeen summarizes his

first article by saying, "It does not seem premature or too optimistic to say
that it is believed that most of them can look forward to a complete cure and
restoration of function.

It may be that in some of the more advanced cases

only a retardation or a halt in the growth with firm encapsulation and without

,,....,I

dense ossification will result from the treatment; but if so, these cases
will be in a much better position for curettage than they were prior to the
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radiation, and it does not appear unwise, before advising a patient to submit
to an amputation on account of the size and location of the

t~or,

and the

fact that it may have broken through into a joint, to give roentgen ray treatment a fair trial to obviate the loss of a limb by amputation."
A follow-up of Herendeen's cases, previously cited, shows that all
of those considered in the previous report continued to improve or have remained free.or· ey: sign of recurrence or presence of actively growing tumor,
except two.

One case developed a recurrence, but, on treatment, responded

favorably and the condition at this time is quite satisfactory.
was treated under a mistaken diagnosis and came to amputation.

Another case
This tumor,

when examined in the laboratory, was found to be locking in many of the
essential features of a giant-cell tumor and resembled considerably what Ewing
terms as a telangiectatic sarcoma.

This patient is alive and well today with

no evidence of the disease present.

It shou:Ld be emphasized that the great-

est value of radiation in the treatment of giant-cell tumor appears to be in
those cases where the tumor has so destroyed the end of a weight-bearing bone
that the logical procedure is amputation.

It is obvious that the va1ue of a

simple curettement in such cases lies only in the ability to completely remove the tumor.

This frequently cannot be, or is not accomplished.

If, how-

ever, the tumor is completely removed, a shell-like cavity remains, so fragile
that the limb is of no value for weight-bearing purposes.

A number of such

cases have been followed for a considerable period and it was only after a
lapse of years that it has been possible to demonstrate in the radiographs
the production

of~

considerable quantity of new bone.

Furthermore, the

hazards of infection or destruction of the joint surfaces in such cases are
considerable.

There are numerous instances where curettement of a small tumor

is the logical treatment, but even in these instances, it is doubtful,
according to Herendeen, if radiation cannot accomplish as much as curettage
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in the relief from pain and saving of time in restoring the limb to usefulness

(44). Dr. Coley (25) believes with Dr. Herendeen that it is now possible to
state definitely

t~at

giant-cell tum.or can be cured by radiation but disagrees

with him on the period of disability.

Coley is of the opinion that the time

required to effect a cure by radiation is considerably longer than that required by operative treatment or by toxins, with or without curettage, and
hence the period of disability is prolonged.

The chief disadvantage of radi-

ation as a routine, primary method of treatment of giant-cell tum.or lies
in the fact that in a considerable number of cases the diagnosis of benign
giant-cell tumor cannot be made from clinical and roentgen-ray data1lone.

Dr. Coley still firmly believes that it is possible to cure these cases of
giant-cell tum.or most rapidly and certainly by surgery (curettage) followed
by toxins.

"This method," he says, "requires a much shorter period of dis-

ability and is not associated with greater risk".

Platt (SO) and Cotton (28}

believe that operation is absolutely preferable to irradiation.

Cotton says,

"I would go even further and say that irradiation usually acts to stimulate
the tum.or growth, the curative effect beginning only later and at the expense
of unnecessary deformity from loss of bone.

He believes that only when such

tumors are found in the spine (60) is the x-ray to be chosen as a means of
treatment.

Dr. Herendeen (45, 46) reports several cases in 1930 and 1931 to
substantiate his statements that roentgen-ray therapy is perhaps best suited
for the treatment of giant-cell tumors.

Herendeen (46) states that there is

no standardized method of irradiating these tumors.
dose.

There is no roentgen-ray

The amount of radiation given to the tumor and the methods of deliver-

ing it vary with the case.
dose of roentgen-rays.

Few of these tumors respond alike to the same

Radiosensitivity varies, as does that of other tumors,
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with the presence or absence of many factors, which include age of the patient,
location of the tum.or, rate of growth, and the local effort at growth restraint.
It has been found that owing to the susceptibility of these tumors, they can
be destroyed through the application of lighter doses which are not followed
by an extreme degree of reaction.

Bone regeneration seems to follow more

promptly when lighter doses are employed.

Special care should be taken during

the early stage of the treatment of these tumors to protect the part from
injury, and especially to protect the tumor from pressure in a weight-bearing
limb, but it is seldom necessary to apply plaster splints, or to hospitalize
the patient.
In the knee joint cases, Herendeen (46) gives on the average of
eight or ten treatments, a series consisting of three exposures, the exposures
from three or four days to a week apart, the portals consisting in the external, anterior and internal surfaces, using the so-called low voltage ;technic,
140 kilovalts, 4 milliamperes of current, 4 millimetres of aluminum filters,
12-inch target skin distance and from 12 to 15 minutes' exposure.

An interval

of approximately six weeks to two months is allowed to elapse before these
treatments are repeated; but a great deal of variation occurs in the dosage
and methods of delivering it.

The roentgenologist must himself determine the

amount to be given in each case at each treatment, and the decision as to how
much to give and when to give it can be arrived at only through careful
questioning of the patient, examining the part under treatment, and inspection
and comparison of the radiographs:obtained from time to time.
Pfahler (79) recommends the use of high voltage roentgen rays and
filtration through 0.5 mm. Cu.

When dealing with large bones, suc:h as a

lesion in the upper extremity of the humerus or the lower extremity of the
femur in a large man, the 200 kv. technique is essential.

His technique in
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the treatment or giant-cell tumors consists of fractional cases.

None or the

cases in Pfahler's series have shown the swelling, increased pain, and marked
increase in the decalcified area such as has been reported by Herendeen

(46)~

Pfahler and Parry (79) believe that such symptoms are due to the massive dose
technique.

Pfahler emphasizes that, "In osteogenic sarcoma, rapid saturation

with radiation to the limit of normal tissue toleration is justified in order
not to lose the radiosensitivity, but in giant-cell bone tumors this is not
essential and one is less apt to interfere with the repair, or to set up an
osteitis.

This fact makes an accurate diagnosis essential."

In general,

Pfahler recommends treatment with high voltage roentgen rays, filtered through
0.5 mni. of copper, at a distance of 50 cm., 25% skin erythema doses given
successively through one, two, three or four fields of entry.

If the case is

clearly a giant-cell tumor, these treatments need not be given more than three
times a week, but if there is any doubt, the treatment should be given daily
until the tumor area has been brought to 100% of a skin erythema dose according to the "saturation technique" of Pfahler.

If a satisfactory diagnosis

of giant-cell tumor is made, the treatment need not be crowded, but in all
cases one must keep account of the total dosage, and not give sufficient to
produce secondary degeneration.

Degenerative effects are due to the total or

cumulative dosage and may occur when no erythema has ever been produced.
This amount varies with the location and condition of the soft tissues.

After

the treatment during three jeeks, one can allow an interval of about six weeks
to two months and then re-study the case and treat accordingly.
The most common site for giant-cell tumors is in the ends of long
bones, and therefore when they occur in young children they are in the
neighborhood of the epipbyses.

For this reason, many physicians hesitate to

have these cases treated by irradiation.

However, Borak, after reviewing all
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of the records, concludes that.no normal bone has_been found damaged in any
of the cases unless there has been some damage to the-overlying tissues.
Pfahler and Parry (79) have also found this to be true.

Of the twenty-six

cases of giant-cell bone tumor which have been referred to

~hem

for treat-

ment between 1906 and 1931, all cases have shown a definite and satisfactory
response, more satisfactory in the young than in the adult.
In 1932 Dr. Carleton Peirce (76)(77) reviewed the nineteen cases
of giant-cell tumor which were diagnosed as such by the Department of Roentgenology of the University of Michigan from 1924 to 1932.
include any with involvement of either maxilla or :mandible.

This group does not
Fourteen of these

confirmed by histopathologic study are analyzed, ten considered clinically
cured, two presenting malignant features.

They found that roentgen irradi-

ation in repeated relatively moderate doses offers the most for the patient,
except when for cosmetic or functional reasons better results could be obtained with the addition of surgical intervention.

Surgical intervention

should not follow roentgen therapy short of six weeks to two months.

If

surgery is contemplated, thorough curettage and equally thorough chemical
cauterization of the cavity should be executed, followed immediately by a
consistent roentgen therapy program (74).
__ LeWold (59), Kraft (57), Evand and Leucutia (33) and Desjardins (30)
have als9 reported the successful use of roentgen ray therapy in these giantcell tumors.

The use ol radium in the treatment of giant-cell tumors has not

met generally with much success, however, Coley (26) reports a case successfully treated with a radium pack and Coley's toxins.

The high cost of a ra-

dium pack makes its use almost prohibitive in the average institution.
Hitzrot (48) believes that the implantation of radium as a part
treatment in curettement is not advisable because of the delay in healing
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produced by the action of the radium.
It is very generally believed that it is possible to make a correct
diagnosis of giant-cell tumor from the clinical and roentgenologic evidence
alone, but Coley (26) shows that records at the Memorial Hospital and the
Hospital for Ruptured and Crippled have proved that to rely on such evidence
alone results in error in about one out of every five cases, or, in twenty
per cent.

Inasmuch as such an error may result in the loss or life or the

patient, it is not justifiable in taking such a risk if there is any safe way
by which a correct diagnosis can be made before treatment is begun. ·While·it

bas now been proved that giant-cell tumors of the bone can be cured by roentgenray, by no means can all such cases be cured by radiation.

The chief objec:..

tion to radiation as the method of choice is that it is not always possible
to be certain that a given tumor is a benign giant-cell tumor, and if radiation is continued indefinitely in such a case, metastasis may develop before
the error is recognized.

Hence, the importance of making a correct diagnosis

early in all cases of central tumor of the long bones justifies an exploratory
operation, and far outweighs all the disadvantages associated with such
exploration.
This exploration should not be a mere biopsy, and should be undertaken only by the surgeon who is to have future charge of the patient, aiid who
has had sufficient experience with bone tumors to enable him to carry out the
most careful surgical technique.

In all cases of giant-cell tumor, the entire

tumor should be curetted down to healthy bone, and the cavity swabbed out
with zinc chloride.

Therefore, the so-called exploratory operation is not a

biopsy but, is the method of choice to be employed in the treatment of giantcell tumors.

In this opinion of Coley's (26), Bloodgood (13) and most surgeons

here and in Europe concur.
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If the microscopic examination shows that the tumor is of a definitely malignant, metastasizing type, then amputation can be performed,
following this with prophylactic toxin treatment.

The use of toxins after

curettage for giant-cell tU1Dor is advocated by Coley but declared unnecessary
by Bloodgood.

To substantiate their procedure for treatment Coley offers a brief
resume of a series of cases, diagnosed as benign giant-cell tumor from clinical and roentgen ray evidence,

wh~ch

later proved to be malignant.

It is

interesting to note that one of these cases was selected from all the giantcell tU1Dors obs.erved at the Memorial Hospital, and included by Dr. Kolodny
(55) in his admirable and exhaustive review of the Bone Sarcome Registry data,

as a typical examination of giant-cell tumor.

CASE I
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CASE I

llra. lt.K., age 25, white, entered University Hospital on 3/12/JJ
.coaplainiDg

01·:

(l) Pain below left knee :ror six months
(2) Graduall:T inereasing t1801" mass bel.ow lett knee 1·or su: months.
Bistorz:- Trauma to iert knee area in 1931 with considerable pain.

•

Condition apparent.17 cleared With no known complications.
area in October 19J4':!

wi~h

Trauma to same

resulting 1·racture or upper portion 01· lert tibia.

Roentgenogrus taken in December 1932 because ot· aoderate enlargement at
site or fracture.

Diagaosis o:r bone C)"st aa.de at that time.

progressive enlargement With considerable pain

in

This mass showed

area even When leg 1-obile.

Exaa1 pation:- Nodular enJ.argeaent on antero-latera.l. sur1·ace
upper iert tibia about the size or .ba.lf a nl.nut.

patella - 14 inches.

or

Circumference below let't

Circuarerence below right patella - 13 i/3 inches.

aoentgenographT:- 3/13/33 Radiographic studies ot the left knee
deaonstrates a large CJStiC area .involv1Dg more than halr the diameter 01·
the upper end ot' the t1.bia which shows a pushing out of tae cortex which is

markedl7 thinned. along the lateral. and superior aspect of the external plateau.

There is evidence of ce..U.ular partitions extending through portions

of the eystie area.

There has

been

no e.rfort at new bOne rormation, the

lesion being primarily a destructive

~esion.

3/16/33 Bo eVidence or metastasis involving the

skeletal structures or tbe lung tields.
Operative proeedures:3/14/33 - Drs. Lord and Johnson attending.

aa.de two inches Jateral.q below pate.la and laterall7.

tieal.:cy' eroded

~brough

Small incision

The t1Jll0r had prac-

the tibia n i l and contained rroa 50-100 c.c.

or

CASE
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•Ri-llql11d. •terial •1th rriable tisne Wb.ich was remc>Ted.

Cavity- swabbed

with iodine and packed •ittl iodine saturated gauze.

3/23/33 - Dr. Lord attending. Incision -.de over the head ot
the fibula on tbe lett leg.

'l'mor carlt1 opened and about 40 ce. of soft

semi gelatinous tumr tissue was scooped out.
the primary carlv in the tibia.

This cavity- connected with

Bo1'l cavities

and tilled with llosteg-llorhott boae

1f8.X

nabbed 1fith Tr.

ot Iodine

because or extensiYe hemorrllage.

One container of radium was placed in the center or the wax in the tibial

cavity and one in the tiblilar cavity.

Wound lett open.

Pathological report:

Gr:osa:

SeYeral masses or red he110rrhagie tissue in which are

seen yellowish-gray nodular pieces or tissue.

ll1croscopJ&1

Extensive he110rrhagic areas, some areas showing

giant.Mell roration, other areas shoring more fibrous tisaae, with compara-

tiveq llllitom sized spindle-shaped cells. In these areas giant cells are
comparatively few in nmber. Giant cells muck more numrous in areas showing
degeneration and where :belaorrhage is particularly extensiTe.
Diagnosis:- Osteogenic sarcou.

4/25/33 - Microscopic sections reviewed by Dr. Bloodgood and

Dr. Toll.man - diagnosis changed to

benign

giant-cell t1B0r.

X-Baz Theraw:

3/26/33 - University Hospital - Dr. H. B. Bunt. Total 3000 mg.
hours through 1 ma. Brass, 2 ... Lead, and three-tenths Platinu was given

through 2 Lead capsules in the head of the tibia.

3/30/33 - Methodist Hospital - Dr. B. B. H1B1t.

t

5x100 R,

Copper, 1 Alulli.n•, Ant. , Post. , Lat. , and Med. of upper 1/3 tibia. Inten-

sive x-ray therapy given over the lesion, directed through four parts.

CASE PBESENTATIOIS - CASE I

Progress:

2/8/34 - Check-up x-ray taken:- Tuaor has not increased in
size following operation and radiation.
The patient waa
s)'JIPtom free, UDtU

'Up

Eff'ort at bon;y repair seen.

and about tor oYer a year apparently

118.7 1934, when this area again

became painful.

Re-

adaitted to University Hospital JUDe 26, 1934 because of' severe pain 1n
knee area with profuse draillage.

3/26/34 - Biopsy taken - negative soft tissue.

7/12/34 - Amputation at lower
7/12/34 - Biopsy

third or fenr.

takell - DO evidence of' tUJ10r intiltration

in section through skin, llUSCle and regional l1J1.Ph glands.

Discussioa: This case is unique in its completeness of complications, in spite or judicious treat.ment and obsenance of every precautionary •&sure.
year.

Trauma preceded the recognition or the tumor by owr one

Pain and enlarge•nt with x-ray plates .revealed the tllllOr.

Tlds case

illustrates the ditticulty in •king proper diagnosis even with biopsy.

The

original biopa7 report was. osteogenic tumor, althaugh clinical and x-re:r
evidence tended toward giant-eell tumor.
atter consultation with Dr. Bloodgood.

This biopq report was later changed

The estre• hemorrhagic condition. ot

the tUJIOr necessitated the use of' bone wax.

This condition in itself makes

curette•nt very difficult and because of' the extreme danger or inf'ection,
under the most aseptic conditions, the use of' roentgen theraw, in favorable
eases, where diagnosis is evident, is to be recommended because it obviates
these collpl.icatiollB.
The recurrence of' tumor tissue, well illustrated in this case, is

probably due to incomplete curettage. With extensive involvement of' the

CASE PRESENTATIOIS - CASE I
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tuaorous area, and profuse hemorrhage at operation because or the telangieetatic condition or the tis8118• it is easy to realise the difficulties

confronting the surgeon in his attempt to complete17 eradicate all tumor
tissue.

This recurrence of tissue, loss of weight bearing due to extensiTe
inYOlTement of the tibia and fibula• and possible local malignant changes,

made amputation aboYe the knee a most advisable procedure.
The patient is in good

plates failing to

show~

general health at present, repeated roentgei:l

metastatic nodules.

fl -3-33
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CASE II

Jlrs.

c.c.,

age 21, white,seen by- Dr. Berman Johnson, presented

the following complaints:
(1) Progressive swelling of the lower forearm for twelve months.
(2) More rapid growth dving the past five months while the patient
bas been prepant.

Fusitora enlargement of the distal end ot

P!Jsical En•i•tion:

the forearm on the ulnar side, fira to pal.pa.tio11.
Roentnnologigal enndnatioa:

5/9/.3.3- Roentgenograms show a cystic.

trabeeulated expansion of the distal end ot the ulna measving

~

ea.

with Tery pronotm.eed rarefaction of bone through the region ot expansion.
Diynosis1

Giant-cell tU110r of the distal end of the ulna.

It was decided to treat the case by- radi-

Therapeutic m;ocedursn

ation and to allow the patient to return tor surgery in case a satisfactorT
result was not ol>'f;ained.
Radiation »mm

5/28/.3.3 - .350 R- units of radiation was deliv-

ered into the tmor through ulnar, dorsal, radial and volar po!'ts, delivering

about 1190 R- •its into the tumor itself.
200,000 YOlts, fil'\ered through

I

The

radiation was energized 111'

cu. and 2 mm. Al. at a distance of 60 ca.

The patient returned after one week for tU'E'ther radiation.

(Re-

calcitication is not to be expected for a period or about three months and

during the three weeks di:rectl.J f ollowiltg therapy there ay be slight tU'E'ther
lysis of bone)
ll/20/.3.3 - Patient returned showing a subsidence or the swelling

of the distal right ulnar region and showing slight brownish pigmentation in
the oTerlying skin.

The

circmlterenee of the forearm· at a level two inches
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above the wrist measures
Further
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iDchea at this time.

A.P. and lateral radiographs show the cyst to haTe shr'IJllk

to about half its pr'eTious toi..l volume. It now measures about 2 •.3 • · in
diameter and is 7 cm. in total length.

3.5 cm.

in

The qst originall.7 measured about

diameter and 7 cm. in length. In addition there has been a

cle.tinite increase in calcification through the cortex and along the trabecu-

lation witldn the c;yst.
:Wo further radiation was giTen.

Discusion:

Thia case was included to illustrate the very satis-

taetor;y results obtained b;y radiation therap;y in selected cases. Radiatioa

therap;y is indicated in clinical and roantgenological positive giant-cell
t..-ors.

Best results are obtained where radiation is given 'irithout the

deleterious ettects ot surgical interference tor biopS)".
The cosmetic effect is not as good as might be obtained b;y curettage,

but radiation is preferable to this more radical procedure when the knee area

is extensivel;y involved, necessitating resection, bone grafting, prolonged
disabilit;y and of'tentiaes loss o:r tmction.
Adldttedq, each case is an individual problem. and the inn\11lel'able

factors involved call tor different lines of attack.
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CASE III
llr. E.

•eL.,

Riston:

ml.e, age 60, seen by' Dr. Robert D. Schrock.

Fracture at wrist in 19.30. Wrist splinted. Patient

went to work four JDOnths later. Swelllng continued to slowly increase in
sise.

Injury to this area again in 19.3.3.

lo piln present except rheumatic

pain, not COJttined to this area alone.
§mtou:

Progressive enlargement of distal third of right fore-

arm on the radial side.

GraduaU7 increasing def'ormit7 and d78f'unction.

1'o pain.

aoentgepolo&ical W$&ti91: Roentgenograms reveal large, single,
cystic trabeculated expaneion of' the distal end of the right radius, with
Teey

pronounced rarefaction ot bone through the region of expansion.

A 'Very

thin la7er of' increased density is seen surrounding the expansion on the

ulnar side, and at the base or the radial side.
thin cortical capsule.

This is probabl.J' a verr

There is no evidence of the shaft seen through the

expansion. The ulna is displaced •dialJ.7 and distallJ'.
Diamosis:
Discussion:

Giant-cell t1111or of' distal third of right radius.

This case was included to illustrate the sillplicity"

of diagnosing a trul.7 t;n>ical giant-cell tuaor b7 roentgenological and
clinical enllination.

The historJ" is typical - t.r&U1118. and slow progressiTe

increase in size of the t-.or, but the absence or pain and advanced age of
the individual teach a lesson ih theuelws 1

~

illustrating that textbook

8191>to11S and generalities nst not be adhered to dogmaticall7.

The absence

of one or JDOre typical findings must not overweigh the bulk of proof.
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CASE IY

Jira. W.R.M., feale, age 21, entered the offices of' Drs. Lord,

Schrock and JQ)nson on April 16, 1934 because ot pain and swelling in the
right wrist area.

Bistoq1 Pain in right wrist since autum of 193.3. lo histo17
of' previous trauma.

Slight swelling in area.

Sng>t.pa: Pain and swelling in right wrist. Some limitation of
llOtion.

Plg!ical emnation:

Enlargement of' distal third of right radius.

Roen'f;genological ua•iMtiop:

Radiograms skow a C7Stie trabecu-

lated area iaTOlYing the epiph7sial portion of the ript radius.

This area

of expansion is surrounded by a thin line of' dense •terial having the same

density as the cortical bone.

A fracture of the articular cartilage is seen.

Clinical and roentgpol.odcal diaposis1
Operatin procedure:

Gian~ell

tmor of' radius.

Dr. Schrock attending. Radial incision made.

Egg shell cortex found surromding single cavity containing jelly-11.Jce sub-

stance grossl7 resembling giant-cell ttm>r tissue.
pack inserted.

Cavity cleared, •.etller

Articular cartilage and dorSUll ot cortex fractured to prevent

radial deviation.

An 1-ediate bone graf't troa the i l i • was transplanted

to the defect, becaue of the insuf't1cient strength in the cortex to maintain the proper position of the wrist upon the forearm.

The graft was

drilled ten or twelve ti.Ms to permit early vasclllarization. The egg-shell
cortex was then tinily collapsed upon this drilled, spongy bone.

Moulded

splint imllObilization..
Microscopic exa•inatioa:
troa a bone cyst in the torearm.

Specimen consists of' light bran :material
Several eections show numerous giant cells

60.
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containing large B1111bers ot nuclei, an iDf'law:tory reaction, and moderate

aononuclear reaction.

Some areas are t)1>1call.7 infl.ammatoey, while others

are masses ot giant cells in a tibro118 •trix.
G£oss J?!tllo1ou:

Taor showed characteristic thinning of cortex

soll&What egg-ahell in appearance, but a little more ..ascular than the true
bone cyst. · The contents were rather well organized granulation-like tissue,
fairly ..ascular and with a detinite limiting membrane.

The articular

cartilage of the radius showed nicel7 the fracture deaonstrable in x-ra7
together with the tracture on the dorsal surface.
Patho1odeJ. diamosis:

Giant-cell tumor of bone.

Progreu:

ll/23/34 - Roentgenograu meal graft bas healed.

I"""-- , good.

lo signs of recurrence. Wrist tends to fiexion.

Position

Placed in cock-up

splint.
3/15/35 - Wrist colling into dorsi-tl.exion position nicely.
Band used aetiv817 and in excellent condition.

Discussioa:

This case is included to illustrate the excellent

results obtainable in favorable cases by surgical procedures.

It is well

to add in this connection, that the surgeon should be well trained in ortllopedic procedures, to transplant bone gratts i:t necessary, to •int.a.in

proper anatoaical relationships or to provide the best functional position
i t permanent fixation is inerltabl.e.
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